Previous 10 | Next 10 |
Does Your List Of Penny Stocks Include These 3? Penny stocks are usually seen as high-volatility, high-risk trades. Rarely does the average retail trader take a large position in penny stocks to invest in them. However, it’s worth mentioning that not all penny stocks are only...
Are These Biotech Penny Stocks On Your Radar This Week? When it comes to finding penny stocks to buy, speculation can fuel momentum. One of the top sectors that play off of this speculation well is biotech. Right now, biotech stocks are some of the hottest in the market. This is...
Lipocine Provides New Regulatory Update on TLANDO™ SALT LAKE CITY , Dec. 4, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the U.S. Food and Drug Admi...
5 Biotech Stocks To Watch This Week When it comes to biotech stocks , there’s plenty to take into account. This goes for biotech penny stocks as well. Considering that many of these companies are in the preclinical or clinical stages, there’s a higher chance that t...
Should These Remain On The List Of Penny Stocks To Buy During Thanksgiving Week? Are you looking for penny stocks to buy right now? Next week is a short one in the markets with Thursday being a holiday and Friday, a half-day. Needless to say, there’s still plenty of opportuni...
Lipocine (LPCN): Q3 GAAP EPS of -$0.07 misses by $0.01.As of September 30, 2020, we had $18.8 million of unrestricted cash, cash equivalents and marketable investment securities compared to $14.1 million at December 31, 2019.Press Release For further details see: Lipocine EPS misses by ...
Lipocine Announces Third Quarter 2020 Financial and Operational Results PR Newswire SALT LAKE CITY, Nov. 10, 2020 SALT LAKE CITY , Nov. 10, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic...
These Penny Stocks On Robinhood Saw A Late Week Surge; Will That Continue In Novemer? Whether you’re looking to buy penny stocks on Robinhood , Webull, TD Ameritrade, E*Trade, or other platforms, the goal is to make money. New interest in making money with stocks has built-in...
Lipocine is about to report data from its clinical study on whether TLANDO can restore testosterone levels in hypogonadal men without the dose titration requirement on November 9, 2020. Low baseline testosterone levels result in a higher risk of serious complications or even death in ...
Lipocine Provides Regulatory Update on TLANDO™ PR Newswire SALT LAKE CITY, Nov. 6, 2020 SALT LAKE CITY , Nov. 6, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders,...
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 02:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal Study PR Newswire Met standard bioequivalence (BE) criteria C max, AUC 0-t , and AUC 0- ∞ C trough criterion was met LPCN 1154 was well tolerat...
Shares of Lipocine Inc. (NASDAQ: LPCN) traded at a new 52-week high today and are currently trading at $8.96. So far today, approximately 78,318 shares have been exchanged, as compared to an average 30-day volume of 32,701 shares. Lipocine Inc., a clinical-stage biopharmaceutical company, foc...